U
Medline Inc. L10
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/27/2025 06/28/2025 03/28/2025
Net Income -0.62% 11.58% 11.58%
Total Depreciation and Amortization 2.02% 4.41% 4.41%
Total Amortization of Deferred Charges 0.00% 11.11% 11.11%
Total Other Non-Cash Items -38.36% 128.74% 128.74%
Change in Net Operating Assets -98.39% -780.70% -780.70%
Cash from Operations -11.91% -21.52% -21.52%
Capital Expenditure 5.61% -45.18% -45.18%
Sale of Property, Plant, and Equipment -- -- --
Cash Acquisitions 100.00% 102.61% 102.61%
Divestitures -- -- --
Other Investing Activities -- -- --
Cash from Investing 89.88% 40.95% 40.95%
Total Debt Issued 247.20% -97.65% -97.65%
Total Debt Repaid -182.27% 97.23% 97.23%
Issuance of Common Stock -- -- --
Repurchase of Common Stock -500.00% 6.25% 6.25%
Issuance of Preferred Stock -- -- --
Repurchase of Preferred Stock -- -- --
Total Dividends Paid -183.33% -158.97% -158.97%
Other Financing Activities -- -- --
Cash from Financing 71.15% -199.41% -199.41%
Foreign Exchange rate Adjustments -50.00% 350.00% 350.00%
Miscellaneous Cash Flow Adjustments -- -- --
Net Change in Cash 144.38% -68.70% -68.70%